1-3 of 3
Susanne Ganepola, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Katrin Wetzko, MD, Matthias Blechschmidt, MD, Kristina Hòˆlig, MD, Kirsten Poppe-Thiede, MD, Susanne Ganepola, MD, Roman Fischbach, MD, Rainer Ordemann, MD, Michael Laniado, MD, Bernhard Schulte-Hubbert, MD, Markus Schuler, MD, Livia Cotta, MD, Dietrich Braumann, MD, Gerhard Ehninger, MD, Frank Kroschinsky, MD
Journal: Blood
Blood (2011) 118 (21): 4057.
https://doi.org/10.1182/blood.V118.21.4057.4057
Published: 2011
Journal Articles

Alemtuzumab but Not ATG Decreases Natural Killer (NK) Cell Activity towards Tumor Targets in the Early Phase after Allogeneic Stem Cell Transplantation.

Olaf Penack, MD, Lars Fischer, MD, Andrea Stroux, Chiara Gentilini, MD, Axel Nogai, MD, Arne Muessig, MD, Susanne Ganepola, MD, Eckhard Thiel, MD, Lutz Uharek, MD
Journal: Blood
Blood (2006) 108 (11): 2869.
https://doi.org/10.1182/blood.V108.11.2869.2869
Published: 2006
Journal Articles

WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia.

Chiara Gentilini, MD, Urte Hilbers, Susanne Ganepola, MD, Carmen Scheibenbogen, Katy Freyberg, Dietger W. Niederwieser, Eckhard Thiel, Lutz Uharek
Journal: Blood
Blood (2005) 106 (11): 598.
https://doi.org/10.1182/blood.V106.11.598.598
Published: 2005